Position in DHR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$64,763
-$62,974 QoQ
Shares Held
340
-39.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1,863
of 2,098 holders
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Operose Advisors LLC holds $122,889 across 3 Diagnostics & Research names. DHR ranks #1 (52.7% of the industry book) .
All Filings in DHR
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $64,763 | 340 | Shares | Sole | 2026-08-13 | |
| 2025-12-31 | $127,737 | 558 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $110,629 | 558 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $120,301 | 609 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $157,030 | 766 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $179,508 | 782 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $243,545 | 876 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $223,865 | 896 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $223,749 | 896 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $207,280 | 896 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $310,621 | 1,252 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $192,960 | 804 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $202,640 | 804 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $213,397 | 804 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $247,958 | 960 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $339,716 | 1,340 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $393,062 | 1,340 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $440,873 | 1,340 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||